Easton Pharmaceutica Stock Analysis
| EAPH Stock | USD 0.0001 0.00 0.00% |
Easton Pharmaceutica is overvalued with Real Value of 8.4E-5 and Hype Value of 1.0E-4. The main objective of Easton Pharmaceutica stock analysis is to determine its intrinsic value, which is an estimate of what Easton Pharmaceutica is worth, separate from its market price. There are two main types of Easton Pharmaceutica's stock analysis: fundamental analysis and technical analysis.
The Easton Pharmaceutica stock is traded in the USA on OTCCE Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Easton Pharmaceutica's ongoing operational relationships across important fundamental and technical indicators.
Easton |
Easton Stock Analysis Notes
The company has price-to-book (P/B) ratio of 0.0. Some equities with similar Price to Book (P/B) outperform the market in the long run. Easton Pharmaceutica had not issued any dividends in recent years. The entity had 1:3000 split on the 30th of April 2009. Parallel Industries Inc. does not have significant operations. Parallel Industries Inc. was founded in 1997 and is headquartered in Toronto, Canada. Easton Pharmaceuticals is traded on OTC Exchange in the United States. To learn more about Easton Pharmaceutica call Evan Karras at 647-362-5700 or check out https://www.eastonpharma.com.Easton Pharmaceutica Investment Alerts
| Easton Pharmaceutica generated a negative expected return over the last 90 days | |
| Easton Pharmaceutica has some characteristics of a very speculative penny stock | |
| Easton Pharmaceutica has a very high chance of going through financial distress in the upcoming years | |
| Easton Pharmaceutica currently holds 3.28 M in liabilities with Debt to Equity (D/E) ratio of 0.43, which is about average as compared to similar companies. Easton Pharmaceutica has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Easton Pharmaceutica's use of debt, we should always consider it together with its cash and equity. | |
| Net Loss for the year was (188.54 K) with profit before overhead, payroll, taxes, and interest of 201.4 K. | |
| Easton Pharmaceutica currently holds about 5.81 K in cash with (188.54 K) of positive cash flow from operations. | |
| Easton Pharmaceutica has a poor financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Health Stocks Slide as Trump Picks Vaccine Skeptic Kennedy - Bloomberg |
Easton Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 134.49 K.Easton Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.08) | (0.08) | |
| Return On Capital Employed | (0.02) | (0.02) | |
| Return On Assets | (0.02) | (0.02) | |
| Return On Equity | (0.03) | (0.03) |
Management Efficiency
The current Return On Tangible Assets is estimated to decrease to -0.08. The Easton Pharmaceutica's current Return On Capital Employed is estimated to increase to -0.02. As of now, Easton Pharmaceutica's Debt To Assets are increasing as compared to previous years. The Easton Pharmaceutica's current Asset Turnover is estimated to increase to 0.13, while Intangible Assets are projected to decrease to under 6 M. Easton Pharmaceutica's management efficiency ratios could be used to measure how well Easton Pharmaceutica manages its routine affairs as well as how well it operates its assets and liabilities.| Last Reported | Projected for Next Year | ||
| Net Current Asset Value | (362.88) | (381.02) | |
| Tangible Asset Value | (497.93) | (522.83) | |
| Enterprise Value Over EBITDA | (15.70) | (14.92) | |
| Price Book Value Ratio | 0.11 | 0.10 | |
| Enterprise Value Multiple | (15.70) | (14.92) | |
| Price Fair Value | 0.11 | 0.10 | |
| Enterprise Value | 3 M | 2.8 M |
Effective leadership at Easton Pharmaceutica drives its competitive edge in the market. Our analysis focuses on how this translates to financial performance and stock value.
Beta 15.582 | Return On Assets (0.01) | Return On Equity (0.03) |
Technical Drivers
Easton Pharmaceutica technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.Easton Pharmaceutica Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Easton Pharmaceutica middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Easton Pharmaceutica. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
Easton Pharmaceutica Outstanding Bonds
Easton Pharmaceutica issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Easton Pharmaceutica uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Easton bonds can be classified according to their maturity, which is the date when Easton Pharmaceutica has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Volcan Compania Minera Corp BondUSP98047AC08 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| International Game Technology Corp BondUS460599AD57 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
About Easton Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Easton Pharmaceutica prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Easton shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Easton Pharmaceutica. By using and applying Easton Stock analysis, traders can create a robust methodology for identifying Easton entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (0.19) | (0.20) | |
| Operating Profit Margin | (0.19) | (0.20) | |
| Net Loss | (0.19) | (0.20) | |
| Gross Profit Margin | 0.15 | 0.14 |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Easton Pharmaceutica to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Fundamentals Comparison Now
Fundamentals ComparisonCompare fundamentals across multiple equities to find investing opportunities |
| All Next | Launch Module |
Complementary Tools for Easton Stock analysis
When running Easton Pharmaceutica's price analysis, check to measure Easton Pharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Easton Pharmaceutica is operating at the current time. Most of Easton Pharmaceutica's value examination focuses on studying past and present price action to predict the probability of Easton Pharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Easton Pharmaceutica's price. Additionally, you may evaluate how the addition of Easton Pharmaceutica to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |